Investors in Health

Claris Ventures SGR makes equity investments in early-stage biopharma companies with a clear vision and solid scientific evidence. We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas. We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence. Claris Biotech I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing" (or the relevant translation).

B4 Investimenti is an independent private equity house established in 2012 with the aim to identify and invest in Italian SMEs characterized by good profitability, clear development prospects, strong vocation for internationalization and leadership positioning in specific market segments in which "Italianness" represents a distinctive factor. B4 Investimenti invests the capital raised from Italian and international investors, including reputable entrepreneurs, managers and professionals, who share its investment strategy, characterized by a "hands-on" approach to investment, which aims to actively contribute to the growth of the portfolio companies, leveraging on some characteristic development drivers such as managerial and organizational structure strengthening, specific investment plans, start (and consolidation) of international expansion and implementation (and acceleration) of aggregational paths. The aim of B4 Investimenti is essentially transforming "small Italian excellences" from "family and/or artisanal" companies to "structured" leading companies.

We are investors in companies that make the difference. We trust in great entrepreneurs, we partner with hard-working visionaries. Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside its partners through its offices in Turin, Milan and San Francisco. Our mission is to generate high-level returns for our investors by turning entrepreneurship and technology into fast-growing and successful companies.

HTH is a Private Venture Capital Investment Company backed by Entrepreneur in the Healthcare Sector. The company provides capital to Early to Mid Stage companies with breakthrough technologies in Life Sciences. The company invests internationally and focuses on Medtech, Biotech, Digital Health and related fields.

Cube Labs, the venture builder in the healthcare technology space in Italy. We are venture builders enabling innovation in the healthcare technology space. We build companies from promising early-stage R&D, and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.

Wellcome Trust is a global charitable foundation dedicated to improving health by funding scientific research. With a focus on both human and animal health, Wellcome Trust supports innovative projects and initiatives that aim to understand and address health challenges. The organization's funding extends across various disciplines, including biomedical science, public health, and medical innovation. Wellcome Trust's contributions play a crucial role in advancing medical knowledge, developing new treatments, and promoting global health equity. Through strategic investments and partnerships, Wellcome Trust continues to drive progress in healthcare, aiming to create a healthier future for all.

Scalebridge Capital is an early-stage VC fund specializing in investing in artificial intelligence (AI) and workflow automation solutions for legacy industries. The firm focuses on supporting startups and companies that innovate in these areas, aiming to modernize traditional sectors by leveraging AI technologies and enhancing workflow efficiencies. Scalebridge Capital provides strategic capital, mentorship, and operational guidance to help startups scale their innovations and achieve market leadership. With a dedicated focus on AI and workflow automation, the firm plays a pivotal role in driving digital transformation and technological advancements across industries. For entrepreneurs and startups in AI and automation seeking early-stage funding and industry expertise, Scalebridge Capital offers tailored support to accelerate growth and innovation.

Blue Lake is a venture capital firm dedicated to investing in and supporting exceptional immigrant founders at the pre-seed and seed stages in the UK. Specializing in B2B and software startups, Blue Lake provides strategic capital and hands-on support to early-stage companies poised for rapid growth. With a commitment to fostering diversity and innovation, Blue Lake leverages its deep industry knowledge and network to empower immigrant entrepreneurs in building scalable and impactful businesses that thrive in competitive markets.

Pretiosum Ventures is a venture capital firm specializing in investments in Enterprise SaaS (Software as a Service) companies poised to redefine the future of business operations. With a focus on scalable and transformative technologies, Pretiosum Ventures partners with visionary founders to accelerate growth and innovation within the Enterprise SaaS sector. By leveraging deep industry expertise and a strategic investment approach, Pretiosum Ventures aims to support companies that are pioneering advancements in digital transformation and driving impactful change across global markets.

Volta Circle is an evergreen VC fund focused on technology-driven solutions and business models that reshape extractive, linear economic systems into circular, regenerative, and restorative ones. Backed by the Lohia family office, the founders and majority shareholders of Indorama Ventures Ltd. (IVL), Volta Circle operates with a team based between London, Geneva, Milan, and Bangkok, strategically investing in innovations that promote sustainability and economic resilience.

Systema Nova Limited (Company No. 12364900), with its registered office at 4th Floor, 100 Cannon Street, London EC4N 6EU, is authorised and regulated by the Financial Conduct Authority (FRN: 970356). Systema Nova invests in early-stage AI & deeptech startups, focusing on sectors such as climate, fintech, and healthtech, supporting innovative ventures poised to make significant technological advancements.

Seek Ventures is a global venture capital firm specializing in investments across various growth phases of technology and internet companies. The firm collaborates closely with visionary entrepreneurs to accelerate their growth and scale. Seek Ventures leverages its extensive expertise and network to drive sustainable success in the digital age. By providing strategic capital and operational support, Seek Ventures aims to empower its portfolio companies to achieve their full potential and make a significant impact in their respective industries. For technology entrepreneurs seeking strategic partnership and growth acceleration, Seek Ventures offers tailored support to navigate and capitalize on opportunities in the dynamic tech landscape.